The crucial involvement of SREBP1 in the induction of SCD1 levels promoted particularly by CAFs in mammary tumor cells is even more clearly demonstrated by the results of SREBP1 pharmacological inhibition which, in MCF-7 cells, led to the disappearance of the SCD1 upregulation promoted by CAF-derived paracrine signalings. The gene discussed is SCD; the disease is breast cancer.